Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How about this?

 This is what some of us would have  like to heard.

He mentions that due to the NDA he cannot comment on the settlement other than to say the PTSC BoD is pleased with the outcome of the litigation and will be proceeding the M&A phase as previously planned.

And a general update similar to:

http://www.ptsc.com/news/press_releases/20071102.asp

Speaking of potential, I've said many times that Patriot is actively seeking to develop a second revenue stream. I want that business to be predictable, product-based, and profitable. Well, we're making good progress on that front. Throughout the summer months I've been meeting with several high-tech companies and, with our CFO and members of the board of directors, we've evaluated more than 30 different companies in different industries from small 3-person startups to established firms with over 100 employees. A few of the meetings were brief; others progressed quite well and we've started a second phase of deeper discussions with some of the better candidates. We're being very thorough in our evaluation, involving each of our board members in turn and tapping outside advisors when that's appropriate. Overall I'm very excited about the prospects for expanding Patriot and broadening our opportunities. I'll be sure to share progress reports as we move along.

An update would do a lot for investors, even if it is not specific, the comunication from JT would keep the investors in the loop (IMO).

glta

Tom

Share
New Message
Please login to post a reply